Group 1: Financial Performance and Investment - The company has been investing in optical terminals, with fixed assets being only a part of the total investment, implemented over five years, gradually increasing depreciation costs [3] - The expected breakeven period for the optical terminal project is short due to its small scale and low investment amount [3] - The company has maintained steady growth and brand effect due to its strong R&D capabilities and extensive service network [4] Group 2: Market Penetration and Product Adoption - The penetration rate of contact lenses in China is low but increasing, influenced by the development of optometry as a discipline [3] - The company aims to enhance the application rate of orthokeratology lenses by training a large number of professional optometrists and establishing community-based optometry service systems [3] - The market for orthokeratology lenses is expected to grow, with a significant increase in user acceptance over the past fifteen years [4] Group 3: Product Differentiation and Competitive Advantage - The company focuses on high-quality, personalized products and services, leveraging over twenty years of industry experience [4] - The company has a comprehensive competitive edge in hard lens products, supported by a robust R&D team and a complete range of products [4] - The company has reduced the number of trial lenses needed by 90% through innovative fitting methods, significantly decreasing fitting time [5] Group 4: Future Outlook and Strategic Positioning - The company has elevated its positioning from a manufacturer of orthokeratology lenses to a comprehensive provider of optometry products and services [4] - Plans to establish over 1,300 optometry centers are in place, with a focus on unified technical management and quality control [5] - The company anticipates a continued increase in market share for orthokeratology lenses, supported by national health guidelines emphasizing their importance in myopia prevention [6]